Related Experiment Video
Updated: May 12, 2026

10:09
Biomechanical Testing of Murine Tendons
Published on: October 15, 2019
13.0K
Initiating Testosterone Therapy Without Indication for Treatment of Low Testosterone Is Associated With Higher Risk
Timothy L Waters1, Julianna E Winter1, Bela P Delvadia1
1Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana.
Sports Health
|April 29, 2025
Summary
Testosterone supplementation is linked to a higher risk of tendon tears and repairs, even in those without diagnosed deficiency. Patients should be informed about this increased risk of tendon injury before starting therapy.
Area of Science:
- Endocrinology
- Orthopedic Surgery
- Pharmacology
Background:
- Growing use of testosterone supplementation in individuals not meeting deficiency criteria.
- Unclear risks associated with testosterone therapy.
Purpose of the Study:
- To investigate the association between testosterone therapy and tendon tears/repairs.
- To compare outcomes in patients initiating testosterone therapy versus matched controls.
Main Methods:
- Retrospective cohort study of over 100,000 male patients initiating testosterone therapy.
- Propensity score matching used to create a control group of nearly 450,000 patients.
- Comparison of tendon tear and repair rates within 1 and 2 years using logistic regression.
Main Results:
- Significantly higher rates of rotator cuff, patellar, and quadriceps tendon tears in the testosterone group.
- Elevated rates of rotator cuff, distal biceps, and patellar tendon repairs observed.
- Increased risk of any tendon tear and repair persisted for up to two years.
Conclusions:
- Testosterone supplementation is associated with increased tendon tear and repair risk.
- This risk is evident for at least two years post-initiation in patients without documented testing.
- Counseling patients on potential tendon injury risk is crucial before therapy initiation.
Related Concept Videos
Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Testosterone: Functions and Regulation
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

